Medicina
Departamento
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (41)
2024
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
2022
-
The EPICTER score: a bedside and easy tool to predict mortality at 6 months in acute heart failure
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2348-2356
2021
2020
-
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: The NEW_SAFE project
BMJ Open, Vol. 10, Núm. 7
-
Randomized study to evaluate the impact of telemedicine care in patients with type 1 diabetes with multiple doses of insulin and suboptimal HbA1c in Andalusia (Spain): PLATEDIAN study
Diabetes Care, Vol. 43, Núm. 2, pp. 337-342
-
Recommendations for specialized nutritional-metabolic management of the critical patient: introduction, methodology and list of recommendations. Metabolism and Nutrition Working Group of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)
Medicina Intensiva, Vol. 44, pp. 1-14
2019
-
Hypersensitivity to alemtuzumab. A safe and effective desensitization protocol: A case report
Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 4, pp. 1016-1020
-
Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients
HIV Medicine, Vol. 20, Núm. 6, pp. 359-367
2017
-
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study
Cytotherapy, Vol. 19, Núm. 8, pp. 927-936
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
-
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
The Lancet Haematology, Vol. 4, Núm. 12, pp. e573-e583
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2015
-
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174
-
The concordance between patients' renal replacement therapy choice and definitive modality: Is it a utopia?
PLoS ONE, Vol. 10, Núm. 10
2014
-
Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort
International Journal of Infectious Diseases, Vol. 26, pp. 83-87
2013
-
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy
Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326
-
Las dietas de muy bajo valor calórico (DMBVC) en el manejo clínico de la obesidad mórbida
Nutricion Hospitalaria, Vol. 28, Núm. 2, pp. 275-285
-
Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: A prospective cohort study
BMC Infectious Diseases, Vol. 13, Núm. 1
2012
-
Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality
Critical Care, Vol. 16, Núm. 6
-
Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 1, pp. 472-478